PRELOAD PRELOAD PRELOAD PRELOAD PRELOAD

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

With five products on the market and a fully-integrated multinational organization in place, BioMarin is providing innovative therapeutics to patients with serious unmet medical needs.

LATEST NEWS

  • BioMarin Announces Second Quarter 2014 Financial Results...  MORE >
  • BioMarin Sells Priority Review Voucher for $67.5 Million...  MORE >
  • Sarah Cannon Research Institute UK and BioMarin Collaborate on EMBRACA Clinical Study in Hereditary Breast Cancer With BRCA Mutation...  MORE >